PWPCM
MDCO

Perella Weinberg Partners Capital Management’s Medicines Co MDCO Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-314,542
Closed -$9.68M – 276
2013
Q2 		$9.68M Buy
+314,542
New +$10.5M 0.66% 47

Other funds holding MDCO

SAC
Smith Affiliated Capital New York $86.5B AUM 5.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Perella Weinberg Partners Capital Management's MDCO Position: Q3 2013 in Review

Perella Weinberg Partners Capital Management sold out of Medicines Co (MDCO) in Q3 2013, closing a stake of 314,542 shares — an estimated $9.68M sold.

Perella Weinberg Partners Capital Management first reported a position in MDCO in Q2 2013 and held it in 1 quarter. The position peaked at $9.68M in Q2 2013. 172 funds tracked by Wall St. Rank hold MDCO as of Q3 2013.

  • Perella Weinberg Partners Capital Management reported no remaining Medicines Co position as of Q3 2013 after selling out during the quarter.
  • Perella Weinberg Partners Capital Management sold 314,542 Medicines Co shares in Q3 2013, an estimated $9.68M.
  • Perella Weinberg Partners Capital Management first reported a position in Medicines Co in Q2 2013 and held it in 1 quarter.
  • Perella Weinberg Partners Capital Management's Medicines Co position peaked at $9.68M in Q2 2013.
  • 172 funds tracked by Wall St. Rank held Medicines Co as of Q3 2013.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.